Skip to main content

Loading market ticker...

Alkem Records Huge Block Deal—But Why Did the Stock Rise?

Alkem Records Huge Block Deal—But Why Did the Stock Rise?

Source: shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Highlights

  • Alkem Laboratories witnessed a block deal worth approximately INR 929.87 crore.
  • Around 17.88 lakh shares changed hands at INR 5,200 per share.
  • ALKEM shares traded higher despite the block deal transaction.

Alkem Laboratories Limited (NSE:ALKEM) witnessed a sizeable block deal transaction on June 2, 2026, with shares worth approximately INR 929.87 crore changing hands during the block deal session. According to exchange data, 17,88,220 shares were traded in Session 1 of the block deal window at a price of INR 5,200 per share.

The transaction represented one of the notable block deals recorded in the market during the trading session. The identities of the buyer and seller were not immediately disclosed in the exchange data available at the time of reporting.


Source: Analysis by Kalkine 

Transaction Executed Below Previous Closing Price

The block deal was executed at INR 5,200 per share compared with the stock's previous closing price of INR 5,314.50. This represented a discount of approximately 2.15% to the previous close.

Block deals are typically used by institutional investors, promoters, private equity investors, or large shareholders seeking to buy or sell substantial quantities of shares without significantly disrupting normal market trading activity.

The transaction was carried out through the dedicated block deal mechanism provided by stock exchanges, which facilitates large-volume trades within a specified trading window.

About Alkem Laboratories

Alkem Laboratories operates in the pharmaceutical sector and is engaged in the development, manufacturing, and sale of pharmaceutical and nutraceutical products. The company has operations across domestic and international markets and maintains a diversified portfolio across therapeutic segments.

The company is part of India's pharmaceutical industry, which serves both domestic healthcare demand and export markets.

Share Performance

Despite the block deal being executed at a discount to the previous closing price, Alkem Laboratories shares traded higher during regular market hours. As on June 2, 2026, the stock was trading at INR 5,330.50, up 0.30% from the previous close of INR 5,314.50.

The stock opened at INR 5,272.50 and touched an intraday high of INR 5,449.00, while the day's low stood at INR 5,272.50. The volume-weighted average price (VWAP) was INR 5,343.09.

Alkem's total market capitalisation stood at approximately INR 63,638.47 crore, while its free-float market capitalisation was around INR 31,069.15 crore.


Source: TradingView

Stock Return Snapshot

The stock has delivered mixed returns across different periods. Over the last one week and one month, ALKEM recorded declines of 1.03% and 1.40%, respectively. On a one-year basis, the stock generated returns of 4.47%.  Looking at longer-term performance, the stock has gained 58.29% over the last three years and 68.72% over the five-year period, according to exchange data. The stock's 52-week high stands at INR 5,933.50, while the 52-week low is INR 4,716.20.

Key Risks

  • Large shareholder exits may influence market sentiment.
  • Future block deals could increase short-term volatility.
  • Pharmaceutical sector regulations may affect business operations.
  • Competitive pressures could impact growth and margins.

Summary

Alkem Laboratories (NSE:ALKEM) witnessed a block deal involving 17.88 lakh shares worth approximately INR 929.87 crore during the June 2 trading session. The transaction was executed at INR 5,200 per share, representing a discount to the previous closing price. Despite the sizeable trade, ALKEM shares traded in positive territory during regular market hours, indicating continued market interest in the pharmaceutical stock.

FAQs

Q: What was the size of the Alkem Laboratories block deal?
A:
The transaction involved 17.88 lakh shares worth approximately INR 929.87 crore.

Q: At what price was the block deal executed?
A:
The shares were traded at INR 5,200 per share during the block deal session.

Q: How did ALKEM shares react after the transaction?
A:
The stock traded higher and was up 0.28% during regular market trading hours.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.